Henrik Wagner
1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
2024) In Cardiovascular Revascularization Medicine(
- Contribution to journal › Article
- 2023
-
Mark
Prognostic Value of Early Sustained Ventricular Arrhythmias in ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention : A Substudy of VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
- 2022
-
Mark
LONG-TERM ADHERENCE TO FLECAINIDE AS A RHYTHM CONTROL THERAPY IN RECURRENT ATRIAL FIBRILLATION - A RETROSPECTIVE COHORT STUDY
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent p2y12 inhibitors -A validate-swedeheart substudy
(
- Contribution to journal › Article
-
Mark
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
- 2020
-
Mark
β-blockers after myocardial infarction and 1-year clinical outcome - A retrospective study
(
- Contribution to journal › Article
- 2019
-
Mark
Mechanical chest compressions for cardiac arrest in the cath-lab : When is it enough and who should go to extracorporeal cardio pulmonary resuscitation?
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
- 2018
-
Mark
Experiences and outcome from the implementation of a national Swedish automated external defibrillator registry
(
- Contribution to journal › Article
- 2017
-
Mark
Bivalirudin versus heparin monotherapy in myocardial infarction
(
- Contribution to journal › Article